Skip to main content
Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
23.94
+0.58 (2.48%)
At close: Mar 9, 2026, 4:00 PM EDT
24.41
+0.47 (1.96%)
After-hours: Mar 9, 2026, 7:49 PM EDT

Elanco Animal Health Revenue

In the year 2025, Elanco Animal Health had annual revenue of $4.72B with 6.22% growth. Elanco Animal Health had revenue of $1.14B in the quarter ending December 31, 2025, with 12.16% growth.

Revenue (ttm)
$4.72B
Revenue Growth
+6.22%
P/S Ratio
2.52
Revenue / Employee
$476,263
Employees
9,900
Market Cap
11.90B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.72B276.00M6.22%
Dec 31, 20244.44B22.00M0.50%
Dec 31, 20234.42B6.00M0.14%
Dec 31, 20224.41B-353.00M-7.41%
Dec 31, 20214.76B1.49B45.64%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teva Pharmaceutical Industries 17.26B
Viatris 14.30B
Dr. Reddy's Laboratories 3.85B
United Therapeutics 3.18B
Amneal Pharmaceuticals 3.02B
Neurocrine Biosciences 2.86B
Hims & Hers Health 2.35B
Lantheus Holdings 1.54B
Revenue Rankings

ELAN News

More News